Dr. Horwitz on Combination CHOP Regimens in Peripheral T-cell Lymphoma | OncLive

Dr. Horwitz on Combination CHOP Regimens in Peripheral T-cell Lymphoma

October 5, 2016

​Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering, discusses the evolving role of CHOP in peripheral T-cell lymphoma. For years CHOP or a similar regimen has been the standard treatment for peripheral T-cell lymphoma.

Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering, discusses the evolving role of CHOP in peripheral T-cell lymphoma. For years CHOP or a similar regimen has been the standard treatment for peripheral T-cell lymphoma.

However, it is only effective for some people, says Horwitz.

Recently, studies have begun investigating novel agents in combination with CHOP. Questions still remain regarding if CHOP is a reasonable backbone and if it improves outcomes for all patients or just specific subgroups of patients, says Horwitz


x